| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a624cffb417e6bd0ab94c4704d5386db |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2019-03-15^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87ac7b71a0f40789404283409d3af11e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2109ef5b24a3f51a5424d3b8906052ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e9f86b5480c1392d1e52b4ef817ba0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2b7c7ec84dda09fb76fbaf340bebb5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b00a503002a05c534876bb2a1381eeb |
| publicationDate |
2019-09-19^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019175379-A1 |
| titleOfInvention |
Markers of synaptopathy in neurodegenerative disease |
| abstract |
The present invention provides in vitro methods for the diagnosis and/or prognosis of synaptopathy and/or neurodegeneration in an individual, for deciding whether to initiate a therapeutic intervention, and for monitoring the efficacy of the therapeutic intervention, all based on the determination of the level of product expression of VAMP-2and/or Syntaxin-1.Advantageously, these markers allow the early detection of synaptopathy in diseases such as Alzheimer's disease. |
| priorityDate |
2018-03-16^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |